サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1791536

生物学的皮膚代替物の世界市場

Biological Skin Substitutes

出版日
ページ情報
英文 180 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.50円
生物学的皮膚代替物の世界市場
出版日: 2025年08月15日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

生物学的皮膚代替物の世界市場は2030年までに6億890万米ドルに達する見込み

2024年に3億7,520万米ドルと推定される生物学的皮膚代替物の世界市場は、2024年から2030年にかけてCAGR 8.4%で成長し、2030年には6億890万米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるヒトドナー組織由来製品は、CAGR 8.7%を記録し、分析期間終了時には4億1,770万米ドルに達すると予測されます。アセラー動物由来製品セグメントの成長率は、分析期間中CAGR 7.7%と推定されます。

米国市場は9,860万米ドルと推定、中国はCAGR8.1％で成長予測

米国の生物学的皮膚代替物市場は、2024年に9,860万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに9,720万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは8.1%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.8％と7.1％と予測されています。欧州では、ドイツがCAGR約6.7%で成長すると予測されています。

世界の生物学的皮膚代替物市場- 主要動向と促進要因のまとめ

なぜ生物学的皮膚代替物は創傷治療で注目されているのか？

生物学的皮膚代替物は、火傷、慢性創傷、外傷の治療において重要な役割を果たし、現代の創傷治療において不可欠な要素となっています。ヒト由来、動物由来、合成由来のこれらの代替物は、損傷した皮膚組織を一時的または永続的に置換し、治癒を早め合併症を軽減する役割を果たします。糖尿病に関連した潰瘍、褥瘡、重度の熱傷の有病率の増加に伴い、生物学的皮膚代替物の需要は臨床と外科の両方の場面で大幅に増加しています。再生医療と組織工学への注目の高まりは、生物学的皮膚代替物の採用をさらに促進しています。研究者やヘルスケアプロバイダーは、優れた皮膚代替ソリューションを開発するために、コラーゲンベースの足場、無細胞真皮マトリックス、生物工学的皮膚移植片を含む高度なバイオマテリアルを活用しています。医療技術の進化に伴い、これらの代用品は患者の転帰を改善するだけでなく、感染のリスクを減らし、瘢痕を最小限に抑えるため、緊急創傷管理にも長期創傷管理にも望ましい選択肢となっています。

技術革新はどのように生物学的皮膚代替物を改善しているのか？

生体材料科学と組織工学の開発は、生物学的皮膚代替物の開発と応用に革命をもたらしています。成長因子や幹細胞を含む生物活性成分の取り込みは、これらの代替物の再生特性を高め、創傷治癒を促進し、治癒時間を短縮しています。研究者たちはまた、3Dバイオプリンティング技術を使って患者固有の皮膚移植片を作製し、レシピエントの身体とのより良い統合を可能にし、全体的な治療効果を向上させることも模索しています。もうひとつの重要な技術革新は、耐久性と生体適合性を高めるために合成素材と生物学的素材を組み合わせたハイブリッド皮膚代替物の開発です。これらの次世代製品は、天然皮膚の構造と機能をより効果的に模倣し、血管新生と細胞再生を改善するように設計されています。さらに、抗菌ペプチドやスマートバイオマテリアルと生物学的皮膚代替物の統合は、特に免疫不全患者における感染リスクの軽減に役立っています。皮膚バイオエンジニアリングの研究が進むにつれ、生物学的皮膚代替物の有効性とアクセシビリティは急速に拡大すると予想されます。

生物学的皮膚代替物の成長を促進する市場動向とは？

慢性創傷の有病率の増加と火傷の世界の発生率の上昇が、生物学的皮膚代替物市場を牽引する主な要因です。ヘルスケアプロバイダーが在院日数の短縮と創傷治療のアウトカムの改善に注力する中、高度な創傷管理ソリューションへの需要が急増しています。さらに、再生能力の低下により皮膚関連の合併症にかかりやすくなる老年人口の増加が、効果的な生物学的皮膚置換療法へのニーズをさらに高めています。市場を形成するもう一つの大きな動向は、美容整形や再建手術における生物学的皮膚代替物の採用が増加していることです。これらの代用品は、瘢痕の修正、腫瘍切除後の皮膚の修復、美観の向上などに使用されています。また、医療ツーリズムの拡大や選択的美容整形手術の増加も市場成長に寄与しています。さらに、先進的な創傷治療研究に対する政府の取り組みや資金援助がこの分野の技術革新を促し、より洗練された費用対効果の高い生物学的皮膚代替ソリューションへの道を開いています。

生物学的皮膚代替物市場の主な成長促進要因は何か？

生物学的皮膚代替物市場の成長は、再生医療の進歩、高度な創傷ケアソリューションに対する需要の増加、火傷や外傷の症例の増加など、いくつかの要因によってもたらされます。生体工学的皮膚移植片やハイブリッド材料の継続的な開発により、急性創傷と慢性創傷の両方に対する治療選択肢が拡大し、患者の転帰が大幅に改善されています。新興市場におけるヘルスケアインフラの拡充も、高度な創傷治療ソリューションへのアクセスが普及するにつれて、市場の成長に寄与しています。さらに、研究機関とバイオテクノロジー企業との協力関係の強化により、生体適合性と治療効果を高めた革新的な代用皮膚の開発が加速しています。医療界が個別化された効果的な創傷ケアの重要性を強調し続ける中、生物学的皮膚代替物の需要は着実に伸び、創傷管理と再建手術の未来に変革をもたらすと予想されます。

セグメント

製品タイプ（ヒトドナー組織由来製品、アセラー動物由来製品）、用途（急性創傷用途、慢性創傷用途）、最終用途（病院最終用途、外来施設最終用途、調査・製造最終用途）

調査対象企業の例

  • Aroa Biosurgery Limited
  • AVITA Medical, Inc.
  • Integra LifeSciences Holdings Corporation
  • Mallinckrodt Pharmaceuticals plc
  • MIMEDX Group, Inc.
  • Organogenesis Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Tissue Regenix Ltd.
  • Vericel Corporation
  • Advanced Wound Care of North Texas PLLC
  • ProgenaCare Global LLC
  • Wound Evolution

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP29588

Global Biological Skin Substitutes Market to Reach US$608.9 Million by 2030

The global market for Biological Skin Substitutes estimated at US$375.2 Million in the year 2024, is expected to reach US$608.9 Million by 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. Human Donor Tissue-derived Products, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$417.7 Million by the end of the analysis period. Growth in the Acellular Animal-derived Products segment is estimated at 7.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$98.6 Million While China is Forecast to Grow at 8.1% CAGR

The Biological Skin Substitutes market in the U.S. is estimated at US$98.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$97.2 Million by the year 2030 trailing a CAGR of 8.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.8% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.7% CAGR.

Global Biological Skin Substitutes Market - Key Trends & Drivers Summarized

Why Are Biological Skin Substitutes Gaining Prominence in Wound Care?

Biological skin substitutes have become an essential component in modern wound care, playing a crucial role in the treatment of burns, chronic wounds, and traumatic injuries. These substitutes, derived from human, animal, or synthetic sources, serve as temporary or permanent solutions to replace damaged skin tissue, promoting faster healing and reducing complications. With the increasing prevalence of diabetes-related ulcers, pressure sores, and severe burn injuries, the demand for biological skin substitutes is rising significantly in both clinical and surgical settings. The growing focus on regenerative medicine and tissue engineering is further enhancing the adoption of biological skin substitutes. Researchers and healthcare providers are leveraging advanced biomaterials, including collagen-based scaffolds, acellular dermal matrices, and bioengineered skin grafts, to develop superior skin replacement solutions. As medical technology evolves, these substitutes are not only improving patient outcomes but also reducing the risk of infection and minimizing scarring, making them a preferred choice for both emergency and long-term wound management.

How Are Technological Innovations Improving Biological Skin Substitutes?

Advancements in biomaterial science and tissue engineering are revolutionizing the development and application of biological skin substitutes. The incorporation of bioactive components, including growth factors and stem cells, has enhanced the regenerative properties of these substitutes, accelerating wound healing and reducing healing time. Researchers are also exploring the use of 3D bioprinting techniques to fabricate patient-specific skin grafts, enabling better integration with the recipient's body and improving overall treatment efficacy. Another significant innovation is the development of hybrid skin substitutes that combine synthetic and biological materials to enhance durability and biocompatibility. These next-generation products are designed to mimic the structure and function of natural skin more effectively, providing improved vascularization and cellular regeneration. Additionally, the integration of antimicrobial peptides and smart biomaterials with biological skin substitutes is helping reduce infection risks, particularly in immunocompromised patients. As research in skin bioengineering continues to progress, the effectiveness and accessibility of biological skin substitutes are expected to expand rapidly.

What Market Trends Are Driving the Growth of Biological Skin Substitutes?

The increasing prevalence of chronic wounds and the rising global incidence of burn injuries are key factors driving the biological skin substitutes market. As healthcare providers focus on reducing hospital stays and improving wound care outcomes, demand for advanced wound management solutions is surging. Moreover, the growing geriatric population, which is more susceptible to skin-related complications due to reduced regenerative capacity, is further fueling the need for effective biological skin replacement therapies. Another major trend shaping the market is the increasing adoption of biological skin substitutes in cosmetic and reconstructive surgery. These substitutes are being used for scar revision, skin restoration following tumor excision, and aesthetic enhancements. The expansion of medical tourism and the rising number of elective cosmetic procedures are also contributing to market growth. Additionally, government initiatives and funding for advanced wound care research are encouraging innovation in the field, paving the way for more sophisticated and cost-effective biological skin substitute solutions.

What Are the Key Growth Drivers for the Biological Skin Substitutes Market?

The growth in the Biological Skin Substitutes market is driven by several factors, including advancements in regenerative medicine, increasing demand for advanced wound care solutions, and rising cases of burn and trauma injuries. The continuous development of bioengineered skin grafts and hybrid materials is expanding treatment options for both acute and chronic wounds, significantly improving patient outcomes. The expansion of healthcare infrastructure in emerging markets is also contributing to market growth, as access to advanced wound care solutions becomes more widespread. Furthermore, the increasing collaboration between research institutions and biotech firms is accelerating the development of innovative skin substitutes with enhanced biocompatibility and therapeutic potential. As the medical community continues to emphasize the importance of personalized and effective wound care, the demand for biological skin substitutes is expected to grow steadily, transforming the future of wound management and reconstructive surgery.

SCOPE OF STUDY:

The report analyzes the Biological Skin Substitutes market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Human Donor Tissue-derived Products, Acellular Animal-derived Products); Application (Acute Wounds Application, Chronic Wounds Application); End-Use (Hospitals End-Use, Outpatient Facilities End-Use, Research & Manufacturing End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 52 Featured) -

  • Aroa Biosurgery Limited
  • AVITA Medical, Inc.
  • Integra LifeSciences Holdings Corporation
  • Mallinckrodt Pharmaceuticals plc
  • MIMEDX Group, Inc.
  • Organogenesis Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Tissue Regenix Ltd.
  • Vericel Corporation
  • Advanced Wound Care of North Texas PLLC
  • ProgenaCare Global LLC
  • Wound Evolution

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Biological Skin Substitutes - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Chronic Wounds and Burns Throws the Spotlight on Next-Generation Biological Skin Substitutes
    • OEM Focus on Bioengineered Dermal Matrices and Cellular Grafts Drives Innovation in Regenerative Healing
    • Growth in Surgical Wound Closure and Cosmetic Dermatology Supports Use of Skin Substitutes in Aesthetic Procedures
    • Increased Adoption in Diabetic Foot Ulcers and Venous Leg Ulcers Spurs Expansion of Clinical Indications
    • Regulatory Approvals for Allograft, Xenograft, and Acellular Matrices Strengthen Product Diversity
    • Surge in Military and Trauma-Based Injury Management Accelerates Market for Rapid Tissue Replacement Solutions
    • OEM Advances in Cryopreservation and Sterilization Techniques Enhance Shelf Life and Field Usability
    • Integration With Negative Pressure Wound Therapy and Moist Wound Healing Systems Boosts Treatment Synergy
    • Rising Demand for Bioactive Substitutes With Growth Factors and Antimicrobial Properties Enhances Clinical Value
    • Expansion of Hospital Burn Units and Specialized Wound Clinics Drives Institutional Procurement
    • Shift Toward Point-of-Care and On-Demand Skin Substitute Manufacturing Enhances Procedural Agility
    • Use of Autologous Cell-Seeded Scaffolds and 3D Bioprinting Propels Market for Personalized Regenerative Solutions
    • OEM Investment in Pediatric and Neonatal Skin Substitute Applications Expands Age-Specific Product Development
    • Rising Awareness of Limb Salvage and Scar Minimization Strategies Drives Demand for Biological Dressings
    • Strategic Collaborations Between Biotech and Wound Care OEMs Strengthen Pipeline Commercialization
    • Public Funding for Complex Wound Research Supports Academic and Translational Product Development
    • Global Expansion of Organ and Tissue Donation Infrastructure Enhances Availability of Human-Derived Allografts
    • Increasing Preference for Minimally Invasive Wound Management Fuels Market for Sprayable and Sheet-Based Substitutes
    • Growth in Outpatient and Home Wound Care Models Promotes Use of Biologic Dressings With Simple Application Protocols
    • Emphasis on Cost-Effectiveness and Quality-Adjusted Life Years Supports Reimbursement of Advanced Skin Substitutes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Human Donor Tissue-derived Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Human Donor Tissue-derived Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Acellular Animal-derived Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Acellular Animal-derived Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Acute Wounds Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Acute Wounds Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Chronic Wounds Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Chronic Wounds Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Outpatient Facilities End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for Outpatient Facilities End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Research & Manufacturing End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Research & Manufacturing End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World Biological Skin Substitutes Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Biological Skin Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Biological Skin Substitutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biological Skin Substitutes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030
  • CANADA
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030
  • JAPAN
    • Biological Skin Substitutes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Japan 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030
  • CHINA
    • Biological Skin Substitutes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 36: China Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: China 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030
  • EUROPE
    • Biological Skin Substitutes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Europe 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Biological Skin Substitutes by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Biological Skin Substitutes by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • FRANCE
    • Biological Skin Substitutes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 52: France Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030
  • GERMANY
    • Biological Skin Substitutes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030
  • UNITED KINGDOM
    • Biological Skin Substitutes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 70: UK Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Europe 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Biological Skin Substitutes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Biological Skin Substitutes by Type - Human Donor Tissue-derived Products and Acellular Animal-derived Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of World 6-Year Perspective for Biological Skin Substitutes by Type - Percentage Breakdown of Value Sales for Human Donor Tissue-derived Products and Acellular Animal-derived Products for the Years 2025 & 2030
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Biological Skin Substitutes by Application - Acute Wounds Application and Chronic Wounds Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Biological Skin Substitutes by Application - Percentage Breakdown of Value Sales for Acute Wounds Application and Chronic Wounds Application for the Years 2025 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Biological Skin Substitutes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Biological Skin Substitutes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2025 & 2030

IV. COMPETITION